The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice

• Published in: Allergy and asthma proceedings Vol. 42; no. 4; p. 350
• Main Authors: Engin, Ayse, Oktelik, Fatma B, Gelincik, Aslı, Sin, Aytul, Sin, Betul A, Dursun, Berna A, Beyaz, Sengul, Gorgulu, Begum, Cetin, Esin, Deniz, Gunnur
• Format: Journal Article
• Language: English
• Published: United States 01.07.2021
• Subjects: Allergens; Animals; Arthropod Venoms; Bee Venoms; Humans; Hymenoptera - immunology; Hypersensitivity - diagnosis; Immunoglobulin E; Insect Bites and Stings - diagnosis; Wasp Venoms
• ISSN: 1539-6304
• DOI: 10.2500/aap.2021.42.210024

Hymenoptera venom allergy is an immunoglobulin (Ig) E mediated hypersensitivity reaction to Hymenoptera venoms. Obvious identification of the culprit insect that causes the clinical symptoms and, hence, the accurate selection of venom for curative treatment, is of great importance for the effectiveness and safety of venom immunotherapy. In this study, the contribution of component-resolved diagnostics (CRD) is evaluated in the diagnosis of Hymenoptera venom allergy. Ninety-three patients from four different centers in Turkey were included in the study. Conventional tests, including prick and intradermal skin tests, with commercial venom extracts and serum specific IgE (sIgE) levels for whole venoms were performed. An sIgE analysis for venom allergen components, including rApi m 1, rApi m 2, rApi m 10, rVes v 1, rVes v 5, were evaluated by immunoblotting. In conventional test results, 17 of 35 patients with bee venom allergy were positive to honey bee venom, whereas 18 patients were positive to bee and wasp venoms. In 28 of 35 patients with bee venom allergy, the diagnosis was confirmed with CRD. CRD revealed a sensitivity of 80% in patients with bee venom allergy. According to conventional tests, 7 of 24 patients with vespid venom allergy demonstrated sensitivity only to species, whereas 17 patients revealed double positivity. The total diagnostic sensitivity of Ves v 1 and Ves v 5 was calculated as 87.5%. Ten of 23 patients with a history of hypersensitivity to both venoms showed double sensitivity with CRD; one patient had cross-reactivity, one patient was found to be sensitive only to bee venom, and, eight patients were sensitive only to species. Eleven patients had an uncertain history in terms of the culprit insect type and six of them had double sensitivity in CRD. CRD seemed to be more helpful in diagnosing vespid venom allergy than bee venom allergy. It can also discriminate clinically significant sensitizations from irrelevant ones.